A recent report on Beckers Hospital Review offers a look at 20 drugmaker transactions and partnerships which the outlet has covered so far in 2018, including the $2.4 billion acquisition of Foundation Medicine by Roche.
” … Experts from some of the largest drug manufacturers are expecting the pace of deals in 2018 to significantly accelerate as a result of the tax overhaul,” the Beckers Hospital Review report states.
Below are some of the other movements in the industry, according to Beckers Hospital Review:
- J&J divests LifeScan unit for $2.1 billion;
- Stryker makes takeover bid for Boston Scientific;
- Takeda acquires Shire for $62 billion; and
- Shire sells oncology unit in $2.4 billion deal.